Emerging cardiovascular technology, trends in ambulatory care, provider and payer partnerships, and value-based arrangements create strategic opportunities to address service demand and cost pressures ...

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), a pioneer of artificial intelligence-driven precision cardiovascular medicine tests, today announced its AI-driven molecular ...

Jun. 10, 2025 8:35 AM ETCardio Diagnostics Holdings, Inc. (CDIO) “We are proud to support this important innovation from the University of Iowa ecosystem,” said Marie Kerbeshian, Ph.D., Executive ...

Johnson & Johnson sealed its biggest deal in six years by acquiring cardiovascular med tech company Abiomed for $16.6 billion, the company announced Tuesday. Abiomed, which develops heart pumps, will ...

Johnson & Johnson will spend $16.6 billion to buy cardiovascular technology company Abiomed to strengthen its medical device division.The health care giant said Tuesday that it will pay $380 for each ...

Modern cardiovascular care involves human acumen, complex data and collaborative intelligence between the two. Payment models are based on well-defined tests and procedures and are baffled by the ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. Johnson & Johnson is spending more than $16 ...

Cardio Diagnostics Holdings Inc. (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced that the Japan Patent Office has issued a patent for ...

FILE - The Johnson & Johnson logo appears above a trading post on the floor of the New York Stock Exchange, Monday, July 12, 2021. Johnson & Johnson is spending about $16.6 billion to buy ...

FILE - The Johnson & Johnson logo appears above a trading post on the floor of the New York Stock Exchange, Monday, July 12, 2021. Johnson & Johnson is spending about $16.6 billion to buy ...